Used in pharmaceutical research as a key intermediate in the synthesis of antibacterial agents, particularly in the development of oxazolidinone-class antibiotics. Its structure supports the inhibition of bacterial protein synthesis, making it valuable in creating drugs effective against resistant strains like MRSA. The compound's chiral center enhances selectivity, improving drug efficacy and reducing side effects. It is also employed in structure-activity relationship (SAR) studies to optimize antibiotic potency and pharmacokinetic properties.